C12
C12 — Malignant neoplasm of pyriform sinus
Billable / specific codeICD-10-CM
C12 is a billable, specific ICD-10-CM code for malignant neoplasm of pyriform sinus. It is valid for submission on a claim.
Use additional code
Add a secondary code to capture the detail described below.
Inclusion terms
Alternative wordings a physician may use in the chart for this same code.
- Malignant neoplasm of pyriform fossa
Risk adjustment
C12 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 21 Lymphoma and Other Cancers0.671 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.
Medicare coverage
C12 is named in 59 Medicare coverage policies — 59 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A52450Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
Questions about C12
- Is C12 a billable ICD-10-CM code?
- Yes. C12 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does C12 sit in the tabular list?
- Neoplasms (C00-D49), in the block Malignant neoplasms of lip, oral cavity and pharynx (C00-C14).